MEDICINE DETAILS
Voranigo
Active ingredient: Vorasidenib
Official EMA and FDA records identify Voranigo as vorasidenib film-coated tablets. Both jurisdictions record 10 mg and 40 mg strengths in 30-tablet HDPE bottles; verify the complete strength and bottle count.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Voranigo used for?
Voranigo (vorasidenib) is indicated for the treatment of Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation. The treatment is indicated for patients over the age of 12, and is applicable after surgery.
Voranigo (vorasidenib) is available as tablets (10 mg and 40 mg).
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Voranigo identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
OFFICIAL RECORD SUMMARY
Product details checked against regulatory sources
Official EMA and FDA records identify Voranigo as vorasidenib film-coated tablets. Both jurisdictions record 10 mg and 40 mg strengths in 30-tablet HDPE bottles; verify the complete strength and bottle count.
- ✓10 mg film-coated tablets — 30-tablet HDPE bottle
- ✓40 mg film-coated tablets — 30-tablet HDPE bottle
- ✓Strength and pack count must be checked together against the prescription and medicine box
Presentations can differ by jurisdiction and authorisation. This list is not a use or dosing recommendation.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
40 mg film-coated tablets · 30 tablets Catalogue organisation: SERVIER Deutschland GmbH
OFFICIAL SOURCES
Check the Voranigo record at an official source.
Search for “Voranigo” or “Vorasidenib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD EMA — Voranigo EPAREuropean public assessment and authorised presentation information for Voranigo.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD FDA — Voranigo prescribing informationFDA-approved U.S. prescribing information and bottle presentations.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Voranigo.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Voranigo
01What is Voranigo?＋
This directory record associates the brand name Voranigo with the active ingredient Vorasidenib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Voranigo strengths and packs are recorded?＋
The catalogue currently shows: 40 mg film-coated tablets · 30 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Voranigo?＋
Catalogue records currently name: SERVIER Deutschland GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Voranigo?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Voranigo, payment request, stock guarantee or binding offer.
06Can I buy Voranigo from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.